MAINZ, Germany, and PRINCETON, USA, June 2, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced that the companies have entered into an agreement for the global co-development and co-commercialization of BioNTech's investigational bispecific antibody BNT327 across numerous solid tumor types. Under the agreement, BioNTech and BMS will work jointly to broaden and accelerate the development of this clinical candidate.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=151206&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

MAINZ, Germany & PRINCETON, N.J.--(BUSINESS WIRE)--BioNTech and Bristol Myers Squibb Announce Global Strategic Partnership to Co-Develop and Co-Commercialize Next-generation Bispecific Antibody.

Bank of America has upgraded Boeing (NYSE: BA) to a Buy rating from Neutral, raising its price target to $260, a Street-high projection from the previous $185.

BRISBANE, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that the primary endpoint was met in the ORIGIN Phase 3 trial of atacicept for the treatment of immunoglobulin A nephropathy (IgAN) in adults.

Interline agreement to connect America's largest domestic carrier and Taiwan-based China Airlines through shared gateways in California, creating first trans-Pacific airline partnership for Southwest Airlines NEW DELHI , June 2, 2025 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) and China Airlines Group, a Taiwan-based carrier, are in discussions to create an interline partnership in early 2026, with published connections expected to go on sale later this year. Executive Leadership from both carriers met this week at the International Air Transport Association (IATA) 2025 Annual General Meeting (AGM) in India to jointly announce the first trans-Pacific airline partnership for Southwest Airlines®.

NEW YORK , June 2, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following investor, scientific and industry conferences in June: June 3-5: Jefferies Healthcare Conference. Daniel Vitt, Ph.D.

Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Chakana Copper Corp. (TSXV: PERU) (OTCQB: CHKKF) (FSE: 1ZX0) (the "Company" or "Chakana"), is pleased to provide this update and outline its exploration plan for the La Joya project in Ancash, Peru. After eliminating all property payments and consolidating its share structure, the Company is focusing its exploration efforts on three mineral rich target areas within the newly defined La Joya project.

Enables UAVs to accomplish very long-range missions in GNSS-challenged environments To be demonstrated at Joint Navigation Conference from June 2-5, Stand 430 CHANDLER, Ariz. , June 2, 2025 /PRNewswire/ -- Inertial Labs, a VIAVI Solutions Inc. (VIAVI) (NASDAQ: VIAV) company, today announced the launch of a visual-aided inertial navigation system (VINS) that enables aircraft to maintain accurate flightpaths when no reliable GPS/GNSS signal is available.

FORT WORTH, Texas , June 2, 2025 /PRNewswire/ -- AZZ Inc. (NYSE: AZZ), the leading independent provider of hot-dip galvanizing and coil coating solutions in North America, today announced that David Nark, Chief Marketing, Communications, and Investor Relations Officer will participate in the Wolfe Research 2nd Annual Materials of the Future Conference 2025. The conference will be held on June 16-18, 2025, at the Wolfe Research Office, 757 Third Avenue - 5th Floor, in New York City, New York.

NYSE American: UEC Highlights: Commissioned first new mine-unit at Christensen Ranch In-Situ Recovery ("ISR") Mine , with Header House 10-7 coming online as part of the phased ramp-up of Wyoming's Powder River Basin operations. Construction advancing at Burke Hollow in South Texas , with major equipment installed at the satellite ion exchange plant and disposal well development in progress.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / If you suffered a loss on your NET Power, Inc. (NYSE:NPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/net-power-inc-lawsuit-submission-form?prid=151209&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq.

Looking at Q1 '25 earnings trends, the healthcare sector reported a solid quarter, even with UnitedHealth's issues. Q2 and Q3 '25 are showing lower or negative revisions, and lower levels of absolute healthcare EPS growth. It looks like Q2 '25 could be the low point for healthcare sector earnings growth for this year, but the sector is being buffeted by a number of headwinds.

Atlanta, June 02, 2025 (GLOBE NEWSWIRE) -- Piedmont Office Realty Trust, Inc. ("Piedmont” or “the Company") (NYSE:PDM), an owner of Class A office properties located primarily in the Sunbelt, announced today, that the Company is participating in this week's Nareit REITWeek Investor Conference in New York City. The Company has completed over 500,000 square feet of leasing thus far in the second quarter, with 350,000 square feet related to new tenants.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Zedge, Inc. (NYSE AMERICAN:ZDGE), $ZDGE, a leader in digital marketplaces and interactive games that provide content, enable creativity, empower self-expression and facilitate community, today announced that CEO Jonathan Reich will participate in a fireside chat at the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow," presented by Maxim Group LLC, on Thursday, June 5th at 11:30 a.m. EDT. This conference will be live on M-Vest.

NEW YORK, NY / ACCESS Newswire / June 2, 2025 / Ares Management Corporation announced today that its Chief Financial Officer, Jarrod Phillips, is scheduled to present at the Morgan Stanley US Financials Conference on Tuesday, June 10, 2025, at 12:15pm ET. A live audio webcast of the presentation will be available on the Investor Resources section of the Company's website at www.aresmgmt.com.

Proceeds to Support Company's Strategic Focus on Data Center Business Proceeds to Support Company's Strategic Focus on Data Center Business

NEW YORK--(BUSINESS WIRE)---- $LZM #BatteryMetals--Lifezone Metals Limited's (NYSE: LZM) Chief Executive Officer, Chris Showalter, and Chief Operating Officer, Gerick Mouton, announce today the results from the Initial Assessment for its flagship Kabanga Nickel Project in northwest Tanzania. The Initial Assessment evaluates a vertically integrated mining, processing and refining operation, commencing with a high-grade nickel sulfide underground mine and concentrator at the Kabanga site, followed five years later by a.

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--CareTrust REIT, Inc. (NYSE:CTRE) (“CareTrust” or the “Company”) announced today that, together with a joint venture partner, it has acquired a portfolio of skilled nursing facilities located in the Pacific Northwest for a total purchase price of approximately $146 million, inclusive of transaction costs. The portfolio consists of 10 facilities comprising 911 licensed beds located across Idaho, Oregon and Washington. The acquisition was completed through a.

MORRISVILLE, N.C., June 02, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that Liquidia is scheduled to make its first commercial shipment of YUTREPIA™ (treprostinil) inhalation powder, marking the first time YUTREPIA will be available to be prescribed to patients at specialty pharmacies. This milestone was achieved only five business days following the U.S. Food and Drug Administration (FDA) approval of YUTREPIA on May 23, 2025, for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).